Zydus Wellness Q1 FY27 Results (NSE: ZYDUSWELL)
Signal: Margin pressure
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹143.7 Cr | 66.9% | -63.7% |
| EBIT | ₹18.84 Cr | 27.5% | |
| Net profit | ₹11.89 Cr | -7.0% | |
| EPS | ₹3.74 | -81.4% | |
| EBIT margin | 13.1% |
P&L walk
Revenue growth of 66.9% was acquisition-led, with cost of materials +15.1%, purchases of stock-in-trade +178.5% and A&P +97.2% growing faster than sales, compressing EBITDA margin 300bps to 17.1%; operating leverage did not fire because EBITDA grew slower than revenue on a margin-bps basis.
Research and educational content only. Not investment advice.